The data is part of an ongoing national lab survey the CDC started in March to test for antibodies against SARS-CoV-2, the virus that causes COVID-19, in commercial lab samples. More than 26,000 lab samples have been tested to show a 79.7 percent prevalence rate, indicating 56,977,000 children have had at least one COVID-19 infection.
The study only researches the detection of antibodies; the antibody percentage, which would indicate someone’s level of protection against infection, is not calculated.
Among the young population, the age groups demonstrated similar antibody levels. Children 5 to 11 years old were the age group with the highest prevalence of SARS-CoV-2 antibodies, with an 82.5 percent prevalence rate in tested samples. Infants between 6 months and 4 years old accounted for a 74 percent prevalence rate.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
